A 200-mg infusion of Keytruda runs around $11,760 for the drug alone; total visit charges depend on site, schedule, and insurance.
What Drives The Per-Treatment Price
Cancer centers bill several parts on infusion days. There is the drug itself, the time and supplies to give it, a facility fee, and routine labs or scans tied to the visit. Your actual bill blends all of those line items, then your plan applies the deductible and a copay or coinsurance. That is why two people sitting in the same chair can see very different totals.
Per-Treatment Cost Range For Keytruda
When people ask what a single visit costs, they want a ballpark today, not a national average. Using retail quotes for the 100 mg vial, the drug portion lands near $11,760 for 200 mg and near $23,520 for 400 mg. The allowed amount your plan uses can be lower or higher, and the visit also includes an administration code and a facility component. In real bills, the all-in total for a 200 mg visit stacks the drug line, an infusion code, a pharmacy or facility fee, a supplies line, and routine labs if drawn that day. Imaging linked to restaging appears on separate claims.
Typical Doses And How That Translates To Units
Adults usually receive a fixed dose: 200 mg every 3 weeks or 400 mg every 6 weeks, delivered over 30 minutes. Pediatric dosing uses 2 mg/kg up to a 200 mg cap. These schedules come straight from the U.S. label and are common across many tumor types.
| Dose Per Visit | Vials Needed* | Sticker Price: Drug Only** |
|---|---|---|
| 200 mg (adult) | Two 100 mg vials | $11,760 |
| 400 mg (adult) | Four 100 mg vials | $23,520 |
| 2 mg/kg up to 200 mg (pediatric) | One–Two 100 mg vials | $5,880–$11,760 |
*Vials supplied as 100 mg/4 mL. **Sticker prices use retail quotations; they do not reflect negotiated insurance rates.
Where Those Dollar Figures Come From
The sticker numbers above reflect retail quotes for the 100 mg/4 mL presentation. Pharmacies list a single vial near $5,884 in recent postings, which puts the 200 mg dose near $11,760 and the 400 mg dose near $23,520 for the drug component before any fees or discounts.
What Insurers Pay Behind The Scenes
Public and private plans rarely pay retail. In Medicare Part B, most outpatient cancer drugs are paid using the average sales price method. The program sets an allowed amount based on the manufacturer-reported average, then adds six percent. Private plans peg their contracts to that benchmark or to their own negotiated schedules. The allowed amount is the number your coinsurance applies to, not the retail figure. Payment benchmarks update quarterly, so the same dose can carry a slightly different allowed amount next quarter. Plans post updates each quarter; clinics know. Ask early.
What People Commonly Pay With Insurance
Under Original Medicare, after the Part B deductible, patients typically owe 20% coinsurance for chemotherapy given in an office, clinic, or hospital outpatient department. You can confirm that rule on the official chemotherapy coverage page. Medicare Advantage plans use plan-specific cost sharing but cap annual out-of-pocket spending. Commercial plans often use 10%–30% coinsurance once the deductible is met. Medigap policies can cover the Part B coinsurance. Medicaid usually keeps cost sharing minimal.
Sample Out-Of-Pocket Math
To make the math tangible, the table below models only the drug portion for a 200 mg visit using an allowed amount of $11,760. Your bill will also include an infusion code, possible premeds, and a facility fee, which vary widely by site of care.
| Coverage Setup | Allowed Amount (Drug) | Estimated Patient Share |
|---|---|---|
| Original Medicare without Medigap | $11,760 | 20% coinsurance = $2,352 |
| Original Medicare with Medigap G or N | $11,760 | $0 after deductible (Medigap pays coinsurance) |
| Medicare Advantage in-network | Plan-contracted rate | Plan coinsurance until the yearly cap |
| Commercial plan with 20% coinsurance | $11,760 | $2,352 after deductible |
| Medicaid | $11,760 | Usually $0–$10 copay |
| Uninsured cash payer | Retail charge | Often full retail unless a financial aid program applies |
How Many Visits And Yearly Spend Look
The number of visits depends on the plan of care and how you respond. Many regimens give this drug until progression or for up to two years. On a 200 mg every-3-weeks schedule, that is around 17 visits in a year, which puts just the drug portion near $200,000 at sticker price. On the 400 mg every-6-weeks schedule, it is around nine visits, making the sticker math similar once you multiply the larger dose by fewer visits. Actual allowed amounts vary by payer and quarter. Stopping earlier trims spend; extending past a year raises it.
Other Line Items That Change The Bill
Infusion services come with their own CPT codes, and higher-acuity hospital departments often bill at higher rates than physician offices. Many centers bill premeds or anti-nausea meds, IV start and flushes, observation time, and post-visit monitoring. Imaging or lab work tied to the same day can add more. If your center mixes a vial and discards the remainder, the claim may include wastage under the discarded-drug policy, which can raise the paid amount for that visit.
Why Charges Vary By Site Of Care
The same drug can carry a different allowed amount in a hospital outpatient department compared with a freestanding office. Contracted rates, pharmacy overhead, handling standards, and 340B status all play a part. That is why a pre-treatment estimate from the exact site matters more than a statewide average.
How We Built The Estimates
Dosing comes from the U.S. prescribing information. Pricing examples use retail quotations for the 100 mg/4 mL vial and translate directly to 200 mg and 400 mg visits. For plan math, we use Medicare’s average-sales-price rule as the anchor and then apply typical coinsurance patterns. Your situation can differ based on plan design, deductibles, assistance programs, and negotiated rates.
Ways To Shrink The Out-Of-Pocket Bill
Ask For A Pre-Treatment Estimate
Request a written estimate from your infusion site. Ask them to list the drug code (J9271) in 1 mg units, the number of units, the administration code, and any planned add-on drugs. This gives you the right inputs to ask your insurer for a benefit check.
Check Manufacturer Support
People with commercial insurance can often reduce coinsurance with the maker’s copay program. Uninsured or under-insured patients may qualify for free drug through a patient assistance program. These programs have income and diagnosis rules, so call early and bring the paperwork to your clinic’s financial counselor.
Use Plan Tools
Search your plan portal for the infusion site that lists the lowest tier for chemotherapy services. Many plans show the contracted rate range for common drugs when you look up a facility. If the plan shows two in-network sites near you, call both and compare the estimate in writing.
Know The Annual Caps
Original Medicare has no out-of-pocket cap but a Medigap plan can erase the 20% share after the deductible. Medicare Advantage sets a yearly maximum for in-network spending. Commercial plans also post an in-network ceiling. If you have reached the cap, your share for the rest of the year should drop to zero at in-network sites.
What If The Dose Or Schedule Changes
Oncologists adjust care when scans or side effects point that way. A switch from every 3 weeks to every 6 weeks doubles the per-visit drug amount but reduces visit count. A weight-based pediatric dose rises or falls with growth. A move from a hospital clinic to a freestanding office can change the allowed amount, even with the same insurer. Any of those shifts can nudge your bill, which is why refreshed estimates during care are useful.
Insurance Terms That Shape The Bill
Deductible: The dollar amount you pay each year before the plan starts sharing costs for non-preventive care.
Coinsurance: A percentage of the allowed amount you pay after the deductible. For Medicare Part B cancer infusions, that share is typically 20%.
Out-of-pocket maximum: The ceiling a plan sets for in-network spending in a calendar year. Once you hit it, in-network costs usually drop to zero for the rest of the year.
Prior authorization: The plan’s approval step before the clinic can give the drug and get paid. Missing paperwork can delay care and lead to denied claims.
Practical Tips For Your Next Appointment
- Bring the current insurance card and any secondary plan card.
- Ask if the pharmacy will use full vials or share vials across patients to reduce waste.
- Confirm whether the 3-week or 6-week schedule applies to your case.
- Ask if lab work is billed by the hospital or by an outside lab.
- Review every claim on your plan portal and appeal coding mistakes quickly.
Answering The Core Question
Per visit, the drug portion often lands near $11,760 for a 200 mg dose and near $23,520 for a 400 mg dose before any discounts, fees, or plan rules. The number you pay depends on your plan’s allowed amount and cost sharing for Part B-type infusions or the equivalent under a commercial plan. A quick call to your infusion site and insurer with the details in this guide will pin down your own figure.
Notes: This article is for cost education and does not replace medical advice, coverage documents, or a signed estimate from your provider. Prices and policies change.